• Novel Therapies for Neovascular Retinal Disease - Expert Analysis of New Key Data

  • Jun 27 2024
  • Duración: 16 m
  • Podcast

Novel Therapies for Neovascular Retinal Disease - Expert Analysis of New Key Data  Por  arte de portada

Novel Therapies for Neovascular Retinal Disease - Expert Analysis of New Key Data

  • Resumen

  • In this PER On Air Ophthalmology Times Podcast, a panel of experts takes a closer look at newer-generation anti-VEGF agents for the treatment of nAMD and DME, sharing insights into clinical trial and real-world data, patient education, and other important considerations for treatment. Faculty: Roger A. Goldberg, MD, MBA Vitreoretinal Specialist Bay Area Retina Associates Volunteer Faculty California Pacific Medical Center Walnut Creek, CA David R.P. Almeida, MD, PhD, MBA President and CEO Erie Retina Research Center for Advanced Surgical Exploration Erie, PA Jennifer I. Lim, MD, FARVO Marion H. Schenk Esq. Chair in Ophthalmology for Research of the Aging Eye UIC Distinguished Professor of Ophthalmology Director, Retina Service Vice-Chair, Diversity and Inclusion University of Illinois at Chicago Chicago, IL
    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Novel Therapies for Neovascular Retinal Disease - Expert Analysis of New Key Data

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.